ETF SCOUTFind. Compare. Invest.
← Back to all ETFs

VanEck Global Healthcare Leaders ETF

About this ETF

The Fund gives investors access to a portfolio of leading international developed markets companies with the best growth at a reasonable price (‘GARP’) attributes from the global health care sector.

IssuerVanEck
Management fee (MER)0.45% p.a.
Inception date10 Sep 2020
BenchmarkMarketGrader Dev Mkt Health Care NR AUD

Scout Score

56/100
Ranked #17 of 50 in Thematic

An independent score calculated by ETF Scout across 7 real-data factors (cost, diversification, tracking, liquidity, fund strength, performance, income), ranked against other funds in the same category.

Cost78
Diversification53
Tracking82
Liquidity25
Fund Strength48
Performance40
Income28

Strengths

  • Tight index tracking — 14.61% tracking error, tighter than 82% of Thematic peers.
  • Low fee — 0.45% p.a., cheaper than 78% of Thematic funds.

Weaknesses

  • Lower liquidity — 0.38% bid/ask spread, wider than 75% of Thematic peers.
  • Below-average yield — 0.32%, lower than 72% of Thematic peers.

Performance (as of 31 Oct 2026)

Total returns, net of fees. Periods longer than 1 year are annualised.

1 Month+5.05%
3 Months+7.16%
YTD+3.03%
1 Year+5.68%
3 Years (p.a.)+9.35%
5 Years (p.a.)+1.82%

Price history

Cumulative return over the selected period, indexed to 0% at the start of the range.

-23%-14%-5%+4%+13%2021-112023-022024-052025-082026-11

Geographic exposure (as at 4 Nov 2026)

Country (where the company is based).

United States flagUnited States
67.34%
Japan flagJapan
12.97%
Denmark flagDenmark
3.99%
South Korea flagSouth Korea
3.32%
Belgium flagBelgium
2.41%
Finland flagFinland
2.27%
United Kingdom flagUnited Kingdom
2.16%
New Zealand flagNew Zealand
1.90%
Switzerland flagSwitzerland
1.88%
Luxembourg flagLuxembourg
1.74%

Sector breakdown (as at 4 Nov 2026)

How your portfolio's holdings are spread across GICS sectors.

Health Care
98.02%
Financials
1.95%

Top holdings (as of 4 Nov 2026)

The fund's largest individual holdings, ranked by portfolio weight.

  1. 1.Idexx Laboratories Inc logoIdexx Laboratories Inc2.51%
  2. 2.Mettler-Toledo International Inc2.42%
  3. 3.Ucb SA logoUcb SA2.41%
  4. 4.Intuitive Surgical Inc logoIntuitive Surgical Inc2.37%
  5. 5.Exelixis Inc2.35%
  6. 6.Eli Lilly & Co logoEli Lilly & Co2.30%
  7. 7.Amgen Inc logoAmgen Inc2.30%
  8. 8.Orion Oyj2.27%
  9. 9.Insulet Corp logoInsulet Corp2.27%
  10. 10.Stryker Corp logoStryker Corp2.23%
  11. 11.United Therapeutics Corp2.22%
  12. 12.Zoetis Inc logoZoetis Inc2.22%
  13. 13.Halozyme Therapeutics Inc2.20%
  14. 14.Agilent Technologies Inc logoAgilent Technologies Inc2.19%
  15. 15.Alk-Abello A/S2.18%
  16. 16.Astrazeneca plc logoAstrazeneca plc2.16%
  17. 17.Regeneron Pharmaceuticals Inc logoRegeneron Pharmaceuticals Inc2.16%
  18. 18.Globus Medical Inc2.13%
  19. 19.Encompass Health Corp2.10%
  20. 20.Tg Therapeutics Inc2.07%